How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder? (Q38859067)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder? (English)

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

0 references

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

object named as

John A Denman

6

0 references

object named as

Jian Li

7

0 references

author name string

Qi Tony Zhou

1

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Zhi Hui Loh

2

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Jiaqi Yu

3

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Si-Ping Sun

4

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Thomas Gengenbach

5

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

language of work or name

0 references

publication date

2 June 2016

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

The AAPS Journal

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

18

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

5

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

1213-1224

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Development of Liposomal Ciprofloxacin to Treat Lung Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Powder Production and Particle Engineering for Dry Powder Inhaler Formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Inhaled formulations and pulmonary drug delivery systems for respiratory infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Inhaled antimicrobial therapy - barriers to effective treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Emerging inhalation aerosol devices and strategies: where are we headed?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Delivery of antibiotics to the respiratory tract: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Pharmaceutical particle engineering via spray drying

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

9 September 2017

Colistin resistance: a major breach in our last line of defence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

25 September 2017

Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

25 September 2017

Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

22 August 2018

The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

22 August 2018

How much particle surface corrugation is sufficient to improve aerosol performance of powders?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5308613

22 August 2018

Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lactose as a carrier for inhalation products: breathing new life into an old carrier. Preface

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large porous particles for pulmonary drug delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/27255350

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1208/S12248-016-9934-X

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38859067&oldid=2202189520"